India, Sept. 28 -- The Government of India has issued a release:
A large multicentre clinical study published recently in Frontiers in Medicine has found that daily administration of a standardised Ashwagandha root extract for 24 weeks was well tolerated, with no evidence of treatment-related liver or kidney injury.
Published on 20 August 2026, (Front. Med., Vol 13, 20 August 2026. https://doi.org/10.3389/fmed.2026.1852954) the study, titled "Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomised double-blind placebo-controlled trial," was conducted by a multidisciplinary team of researchers from 09 institutions, including the Central Council for Rese...